Monday, 12 July 2010

USF receives patent for technology to improve treatment for neurodegenerative diseases

From the MS Trust website:
Umbilical cord blood cells and mannitol pass the blood-brain barrier.
The University of South Florida's Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood (HUCB) cells and a sugar-alcohol compound called "mannitol" that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and stroke, among others.  Read full article here.